Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

10 Senate Dems Line Up On Paper Behind Device Tax Repeal

Executive Summary

There are at least 10 Democrats in the Senate who have either introduced device tax repeal bills in the most recent legislative session or signed on as cosponsors to a repeal bill. Those lawmakers could join all Republicans in the Senate to pass permanent repeal, but a busy Senate agenda and fiscal concerns could stand in the way.

You may also be interested in...



US Midterms: Industry Loses Some Supporters In Congress, But Retains Many

With most of the Nov. 6 election tally completed, it’s clear there will be many new faces for the device industry to engage with in the halls of Congress, but the sector still appears to have a significant group of supporters on Capitol Hill. Also, several medtech-relevant measures were on the ballot.

Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races

Among the very tight Republican and Democrat contests anticipated in this November’s US midterm elections are more than a few device industry-favored candidates, according to a review of the incumbents’ voting records and recent polling data.

US House Votes To Permanently Repeal Device Tax

Lawmakers in the House voted July 24 to permanently repeal the 2.3% medical device excise tax, even as Democrats from Massachusetts and New Jersey vigorously opposed repeal, saying the tax revenue is still needed to uphold the Affordable Care Act. But action in the Senate is unpredictable.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel